Tech Company Financing Transactions
DropGenie Funding Round
On 10/26/2026, DropGenie announced $5 million in Seed investment from Anges Quebec, BDC Capital and Merck Global Health Innovation Fund.
Transaction Overview
Company Name
Announced On
10/26/2026
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to accelerate the commercialization of its first product, expand customer engagement models, and expand its global footprint.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
750 Main St
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Our platform redefines lab automation--enabling high-throughput, low-volume workflows that turn precious patient samples into rich, high-dimensional datasets--accelerating genomic discovery and powering the future of personalized medicine. DropGenie has perfected the miniaturization and parallelization of cell engineering reactions on patented chips. We deliver any editing reagent into any cell type in low volumes, by intelligently tuning electrical parameters with a proprietary electrode configuration.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alison Hirukawa
Browse more venture capital transactions:
Prev: 10/26/2026: adsilico venture capital transaction
Next: 10/26/2026: Omnichat venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs